News

ONSEdge

Certification Makes a Difference Visit ONCC

News


Patricia Frank, RN, BSN, Receives 2012 ONS Emerging Leader Award Awards Granted; 05/18/2012 Patricia Frank, RN, BSN, is the recipient of the 2012 Oncology Nursing Society (ONS) Pearl Moore “Making a Difference” Emerging Leader Award. This award recognizes her as an emerging oncology nurse leader who has made a difference in the oncology nursing profession at the local or regional level.
Anna Schwartz, PhD, FNP, FAAN, Receives 2012 ONS Distinguished Contribution to Nursing Literature Award Awards Granted; 05/16/2012 Anna Schwartz, PhD, FNP, FAAN, of Wilson, WY, associate professor at Idaho State University in Pocatello and affiliate professor at the University of Washington in Seattle, is the recipient of the Oncology Nursing Society (ONS) 2012 Rose Mary Carroll-Johnson Distinguished Award for Consistent Contribution to the Nursing Literature.
Laura Wood, RN, MSN, OCN®, Presents 2012 ONS Clinical Lecture Awards Granted; 05/16/2012 Laura Wood, RN, MSN, OCN®, presented the 2012 Oncology Nursing Society (ONS) Clinical Lecture at the ONS 37th Annual Congress which was held May 3-6 in New Orleans, LA.
Kelly Smith, MSN, RN, NP, AOCN, Named 2012 Advanced Oncology Certified Nurse of the Year Awards Granted; 05/11/2012 The Oncology Nursing Certification Corporation (ONCC) has selected Kelly Smith, MSN, RN, NP, AOCN® as the 2012 Advanced Oncology Certified Nurse of the Year. Smith was selected for the award for her contributions to oncology nursing and oncology nursing service; and for supporting and promoting certification in oncology nursing.
ONCC Honors Froedtert Hospital Awards Granted; 05/11/2012 The Oncology Nursing Certification Corporation (ONCC) has named Froedtert Hospital in Milwaukee, WI, as a recipient of its 2012 Employer Recognition Award. Each year, this award recognizes one institution that employs 25 or more registered nurses for providing sustained support of oncology nursing certification.
ONCC Honors Moncrief Cancer Institute Awards Granted; 05/11/2012 The Oncology Nursing Certification Corporation (ONCC) has selected Moncrief Cancer Institute in Fort Worth, TX, as a recipient of its 2012 Employer Recognition Award. Each year, this award recognizes one organization that employs less than 25 registered nurses for providing sustained support of certification in oncology nursing.
Sylvia Danko, RN, BSN, OCN, CBCN, Named 2012 Oncology Certified Nurse of the Year Awards Granted; 05/11/2012 The Oncology Nursing Certification Corporation (ONCC) has selected Sylvia Danko, RN, BSN, OCN®, CBCN® as the 2012 Oncology Certified Nurse of the Year. Danko was selected for the award for her contributions to oncology nursing and oncology nursing service, and for supporting and promoting certification in oncology nursing.
FDA Approves Pazopanib Tablets FDA Updates; 04/26/2012 The U.S. Food and Drug Administration approved pazopanib tablets (VOTRIENT®, a registered Trademark of GlaxoSmithKline) for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy.
FDA Grants Approval to Everolimus FDA Updates; 04/26/2012 The U.S. Food and Drug Administration granted accelerated approval to everolimus (Afinitor tablets, Novartis) for the treatment of adults with renal angiomyolipoma, associated with tuberous sclerosis complex (TSC), who do not require immediate surgery.
The Regional Cancer Center Receives ONS Employer Recognition Award Awards Granted; 04/18/2012 The Oncology Nursing Society (ONS) has selected The Regional Cancer Center (RCC) in Erie, PA, as the recipient of its 2012 Employer Recognition Award for medium-sized employers. This award recognizes employers who show exemplary support of their registered nurses working in oncology. The award will be presented during ONS’s 37th Annual Congress in New Orleans, LA, on May 3–6.
Report Outlines Innovative Breast Cancer Rehabilitation Model ONS News; 04/11/2012 The Oncology Nursing Society (ONS) is proud to be part of an international initiative that outlines an innovative model to address a wide range of physical issues faced by women with breast cancer and offers hope for improved function and full participation in life activities for patients through rehabilitation and exercise.
Carol Reed Ash, EdD, RN, FAAN, Receives 2012 ONS Lifetime Achievement Award Awards Granted; 04/05/2012 Carol Reed Ash, EdD, RN, FAAN, is the recipient of the 2012 Oncology Nursing Society (ONS) Lifetime Achievement Award. Ash is professor emeritus, Kirbo Endowed Chair, Oncology Nursing at the University of Florida in Gainesville. The award recognizes her outstanding contributions as an oncology nurse researcher, mentor, and educator as well as her service to ONS and the community at large.
Donna Berry, PhD, RN, AOCN®, FAAN, Receives ONS Foundation Research Grant Award Awards Granted; 03/22/2012 Donna Berry, PhD, RN, AOCN®, FAAN, is the recipient of an ONS Foundation Endowment Nursing Research Grant for her project entitled, “ESRA-C Spanish: Linguistic Appropriateness and Cultural Sensitivity.”
Release of USPSTF Final Recommendation on Screening for Cervical Cancer Legislative Updates; 03/16/2012 Today, the U.S. Preventive Services Task Force posted its final recommendation statement on screening for cervical cancer.
March is National Colorectal Cancer Awareness Month Legislative Updates; 03/09/2012 CMS Offers Insight to Colorectal Cancer Awareness Month in March. Of cancers that affect both men and women, colorectal cancer is the second leading cause of cancer-related deaths in the United States and the third most common cancer in men and in women.
ONS Releases Position on Lifelong Learning ONS News; 03/09/2012 Cancer care is rapidly changing, and nurses who care for patients with cancer must commit to lifelong learning to have the expert skills and knowledge they need to provide quality cancer care to their patients. The Oncology Nursing Society (ONS) has released a new position statement on this topic.
FDA’s graphic labeling of tobacco products Legislative Updates; 03/02/2012 On February 29, DC District Judge Richard Leon overturned a lower Court’s decision allowing the FDA’s graphic labeling of tobacco products.
ONS Presents Employer Recognition Award to Moffitt Cancer Center Awards Granted; 03/01/2012 The Oncology Nursing Society (ONS) has selected Moffitt Cancer Center in Tampa, FL, as the recipient of its 2012 Employer Recognition Award for large employers.
ONCC Receives Accreditation of CPHON® Certification ONS News; 02/22/2012 The Oncology Nursing Certification Corporation (ONCC) received accreditation of its Certified Pediatric Hematology Oncology Nurse (CPHON®) program from the National Commission for Certifying Agencies (NCCA). The accreditation is valid through April 30, 2015.
FDA Announces Action to Bolster Supply of Doxil and Methotrexate FDA Updates; 02/21/2012 The FDA announces major actions taken to bolster the supply of Doxil® (Janssen Research & Development LLC.) and preservative-free formulations of methotrexate.
ONS Partners With Congressman to Reintroduce Legislation ONS News; 02/21/2012 The Oncology Nursing Society (ONS) with Representative Steve Israel (D-NY) announced today the unveiling of his legislation, HR 3790, “The Improving Cancer Treatment Education Act of 2012.” The announcement was made at a special event at Huntington Hospital in Long Island, NY.
ONS Honored with Publishing PROSE Award ONS News; 02/13/2012 ONS's award-winning publishing division is pleased to announce that it has received an award from the Professional and Scholarly Publishing Division of the Association of American Publishers.
FDA Grants Regular Approval for Imatinib Mesylate Tablets FDA Updates; 01/31/2012 The U.S. Food and Drug Administration (FDA) granted regular approval for imatinib mesylate tablets (Gleevec®, Novartis Pharmaceuticals) for the adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive Gastrointestinal Stromal Tumors (GIST).
The FDA Approves Vismodegib for Metastatic Basal Cell Carcinoma FDA Updates; 01/30/2012 The U.S. Food and Drug Administration approved vismodegib (ERIVEDGE™ Capsule, Genentech, Inc.) for the treatment of adults with metastatic basal cell carcinoma or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery, and who are not candidates for radiation.
FDA Approves Axitinib Tablets for Advanced Renal Cell Carcinoma FDA Updates; 01/27/2012 The U.S. Food and Drug Administration approved axitinib tablets (Inlyta, Pfizer, Inc.) for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy.
ONS Wins 2011 AJN Book of the Year Award ONS News; 01/26/2012 The American Journal of Nursing (AJN) has awarded the prestigious 2011 AJN Book of the Year Award to the Oncology Nursing Society (ONS) for Advanced Oncology Nursing Certification Review and Resource Manual: Instructor’s Resource, edited by Shirley Triest-Robinson, RN, PhD, AOCNS®, ACNS B, and Wendy H. Vogel, MSN, FNP, AOCNP®, in the Electronic Media category.
Oncology Nursing Society Announces Anne Katz as Oncology Nursing Forum Editor ONS News; 01/25/2012 The Oncology Nursing Society (ONS) is pleased to announce Anne Katz, RN, PhD, as the new editor of the Oncology Nursing Forum (ONF), the Society’s flagship journal. Katz will begin her new responsibility on March 1.
United States Senate Passes a Resolution Recognizing the 40th Anniversary of the National Cancer Act Legislative Updates; 01/19/2012 A resolution recognizing the 40th anniversary of the National Cancer Act of 1971 and the more than 12,000,000 survivors of cancer alive today because of the commitment of the United States to cancer research and advances in cancer prevention, detection, diagnosis, and treatment.
FDA Approves Glucarpidase Injection FDA Updates; 01/17/2012 The US Food and Drug Administration approved glucarpidase injection (Voraxaze®, BTG International Inc.) for the treatment of toxic plasma methotrexate concentrations (> 1 µmol/L) in patients with delayed methotrexate clearance due to impaired renal function.
FDA Approves Changes to Methotrexate Package Insert FDA Updates; 12/21/2011 The US Food and Drug Administration has approved changes to the package inserts for methotrexate products for intravenous administration.
ONS Hosts Health Information Technology Think Tank ONS News; 12/15/2011 The Oncology Nursing Society (ONS) recently hosted a groundbreaking HIT Think Tank in Pittsburgh, PA, to assess ways to support their members as HIT becomes more a part of everyday life in healthcare organizations.
ONS Congratulates Lt. General Horoho Legislative Updates; 12/14/2011 ONS congratulates Lt. General Horoho on her confirmation as the newest Surgeon General of the US Army.
ONCC Announces Innovative Renewal Method for Certified Nurses ONS News; 12/09/2011 Nurses who are certified by the Oncology Nursing Certification Corporation (ONCC) will soon have a new method for renewing their certification credentials.
US Senate Finance Committee Holds Hearing on National Drug Shortage Legislative Updates; 12/07/2011 The US Senate Finance Committee holds hearing on the national drug shortage.
FDA Approves Changes to REMS for Romiplostim and Eltrombopag FDA Updates; 12/06/2011 The Food and Drug Administration (FDA) approved changes to the Risk Evaluation and Mitigation Strategies (REMS) for romiplostim (Nplate for subcutaneous injection, Amgen Inc.) and eltrombopag (Promacta tablets, GlaxoSmithKline LLC) to remove the restricted distribution programs and the safety reporting requirements that were part of the REMS. Prescriber, institution, pharmacy, and patient enrollment and these data collection requirements are no longer necessary.
NCI Launches Smoking Cessation Support for Teens Legislative Updates; 12/05/2011 A new effort to help teens quit smoking will use one of today's teen's most constant companions - the mobile phone. Developed by smoking cessation experts, SmokefreeTXT is a free text message cessation service that provides 24/7 encouragement, advice, and tips to teens trying to quit smoking.
New Breast Cancer Survivor Research Underscores Need for Quality Measures ONS News; 11/22/2011 The ONS Foundation and the Cancer Support Community (CSC) are advancing the understanding of the needs of, and treatment for, breast cancer survivors through two multi-year projects, both funded by The Breast Cancer Fund of National Philanthropic Trust starting in 2009.
FDA Approves Asparaginase Erwinia Chrysanthemi for ALL FDA Updates; 11/18/2011 The US Food and Drug Administration approved asparaginase Erwinia chrysanthemi [ErwinazeTM, injection, EUSA Pharma (USA), Inc.] as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.
President Obama: Great American Smokeout Legislative Updates; 11/18/2011 President Obama: Congratulations to Everyone Taking Part in Today's Great American Smokeout.
FDA Approves Ruxolitinib (Jakafi oral tablets, Incyte Corporation) for the treatment of intermediate and high risk myelofibrosis FDA Updates; 11/16/2011 The US Food and Drug Administration approved ruxolitinib (Jakafi oral tablets, Incyte Corporation) for the treatment of intermediate and high risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis.
FDA Approves Cetuximab FDA Updates; 11/07/2011 The US Food and Drug Administration approved cetuximab (Erbitux®, ImClone LLC, a wholly-owned subsidiary of Eli-Lilly and Company) in combination with platinum-based therapy plus 5-florouracil (5-FU) for the first-line treatment of patients with recurrent locoregional disease and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
NIH Researchers Design Light Therapy Legislative Updates; 11/07/2011 NIH researchers created a light-based therapy that targets and destroys certain tumors and cancers in mice, according to the NCI.
ONS Announces Updates to its Research Agenda ONS News; 10/28/2011 The Oncology Nursing Society (ONS) announces that its Research Agenda, which focuses on gaps in the knowledge base for oncology nursing practice, was updated in 2011.
ONS Collaborates with CDC to Develop an Infection Control and Prevention Plan for Outpatient Oncology Services ONS News; 10/25/2011 The CDC has released a new program called Preventing Infections in Cancer Patients. The program consists of two new tools for patients, their caregivers, and their healthcare providers.
CDC Releases Most Comprehensive Melanoma Report in the US to Date Legislative Updates; 10/19/2011 Melanoma skin cancer has a costly and deadly impact on America. The CDC releases the most comprehensive melanoma report in the United States to date.
FDA Grants Accelerated Approval to Deferiprone FDA Updates; 10/14/2011 The US Food and Drug Administration granted accelerated approval to deferiprone (Ferriprox® Tablets, ApoPharma, Inc.), an oral iron chelator for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.
Breast Cancer Awareness Month Legislative Updates; 10/06/2011 Read a statement from Secretary Sebilius about National Breast Cancer Awareness Month.
White House Goes Pink Legislative Updates; 10/06/2011 October is National Breast Cancer Awareness Month – a time to remember those who have lost their lives to breast cancer and those who are battling it now, and to celebrate with those who have survived. It is also a time to reaffirm our commitment to fighting breast cancer and to remind ourselves of the importance of prevention and early detection.
Changes in Bevacizumab Package Insert FDA Updates; 10/03/2011 Changes in bevacizumab (Avastin®, Genentech, Inc.) package insert regarding: risk of ovarian failure, osteonecrosis of the jaw, risk of venous thromboembolic event (VTE) and bleeding in patients receiving anticoagulation therapy after first VTE event.
FDA Grants Accelerated Approval for Eculizumab FDA Updates; 09/23/2011 the U.S. Food and Drug Administration (FDA) granted accelerated approval for the use of eculizumab (Soliris®, Alexion, Inc.) for the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS).
New Guiding Principles Will Protect ONS's Integrity and Reputation ONS News; 09/20/2011 The ONS Board of Directors approved a new set of guiding principles for corporate support and conflicts of interest (COIs) that is designed to provide a framework for relationships and interactions between ONS and for-profit organizations.
ONS Board Announces 2012-2016 Strategic Plan ONS News; 09/20/2011 After conducting a thorough scan of the oncology healthcare environment, the Oncology Nursing Society (ONS) developed a new five-year strategic plan, which will take effect in 2012.
ONS Overhauls Position Statement Program to Better Address Current Cancer Care Environment ONS News; 09/20/2011 During its July 2011 Board meeting, the ONS Board of Directors conducted a thorough review of Society’s current position statements and noted that some of the current positions no longer speak to a perspective unique to ONS, may no longer be relevant, or are now common practice. As a result, some positions will be revised, some will be combined together and retitled, and others will be archived as they currently stand, with possible key components incorporated into other positions as applicable.
ONS Revamps Approach to Leadership Development ONS News; 09/20/2011 The ONS Leadership Development Institute (LDI) was held annually from 1998–2010. Although the program was well received, the number of nurses participating was limited each year. In response to the current economic climate, the ONS Board of Directors and staff decided to step back and re-evaluate the program, as well as define the leadership needs of the ONS membership and the organization as a whole.
FDA Grants Approval for Denosumab FDA Updates; 09/16/2011 The US Food and Drug Administration granted approval for denosumab (Prolia®, Amgen Inc.) as a treatment to increase bone mass in patients at high risk for fracture receiving androgen deprivation therapy (ADT) for nonmetastatic prostate cancer or adjuvant aromatase inhibitor (AI) therapy for breast cancer. In men with nonmetastatic prostate cancer, denosumab also reduced the incidence of vertebral fracture.
Patient Navigation Supplement Cosponsored by ONS is Published ONS News; 09/16/2011 Together with the American Cancer Society, ONS cosponsored a special supplement that focuses on the importance of patient navigation.
Lung Cancer Rates Decline Nationnwide Legislative Updates; 09/15/2011 A new report shows a continuing decline in rates of new lung cancer cases among men, and a promising decline among women.
ONS Hosts First All-Virtual Conference ONS News; 09/12/2011 Nurses from across the country gathered for the Oncology Nursing Society’s (ONS) Radiation eConference: Radiation Then and Now, and they never had to leave their hometowns. The Radiation eConference is ONS’s first all virtual event.
CDC Releases New Report on Smoking Legislative Updates; 09/07/2011 The CDC releases a new report on smoking. While heavy smoking decreases, light smoking increases.
ONS Offers Resources for Safe Handling of Chemotherapy ONS News; 09/07/2011 Unintentional exposure to hazardous agents such as chemotherapy may endanger the lives of healthcare workers. The Oncology Nursing Society (ONS) offers resources designed to educate nurses on safe handling procedures.
Call for Nurse in Washington Internship Applicants ONS News; 09/02/2011 The Nurse in Washington Internship (NIWI) Program is an annual event sponsored by the Nursing Organizations Alliance. The purpose of the NIWI Program is to provide nurses the opportunity to learn how to influence health care through legislative and regulatory processes. Participants learn from health policy experts and government officials and network with other nurses. The next NIWI is scheduled to be held February 26–28, 2012, in Washington, DC. This year, ONS is offering a limited number of grants for nurses to attend NIWI. The deadline to apply for the grant is November 1, 2011. Recipients of the grants will receive full registration for NIWI, expenses for travel and hotel, and a per diem.
NIH-Funded Researchers Discover Genetic Link to Mesothelioma Legislative Updates; 08/29/2011 Scientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer -- mesothelioma, and melanoma of the eye. Additionally, when these individuals are exposed to asbestos or similar mineral fibers, their risk of developing mesothelioma, an aggressive cancer of the lining of the chest and abdomen, may be markedly increased
FDA Grants Accelerated Approval to Crizotinib FDA Updates; 08/26/2011 The US Food and Drug Administration granted accelerated approval to crizotinib (XALKORI® Capsules, Pfizer Inc.) for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
FDA Grants Accelerated Approval to Brentuximab Vedotin FDA Updates; 08/19/2011 The US Food and Drug Administration granted accelerated approval to brentuximab vedotin (Adcetris™ for Injection, Seattle Genetics, Inc.) for two indications: • The treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates. • The treatment of patients with systemic anaplastic large cell lymphoma (ALCL) after failure of at least one prior multi-agent chemotherapy regimen.
FDA Approves Vemurafenib Tablets FDA Updates; 08/17/2011 The US Food and Drug Administration approved vemurafenib tablets (ZELBORAFTM, Hoffmann-La Roche Inc.) for the treatment of patients with unresectable or metastatic melanoma with the BRAFV600E mutation as detected by an FDA-approved test.
NIH Releases Study Implicating Cigarette Smoking in Half of Bladder Cancers in Women Legislative Updates; 08/16/2011 NIH study confirms bladder cancer risk from smoking is higher than previously estimated.
HHS Awards $71.3 Million to Strengthen Nursing Workforce Legislative Updates; 07/29/2011 The Department of Health and Human Services announces $71.3 million in nursing workforce grants to support training, diversity, and nursing faculty.
ONS Journal CJON Accepted for Indexing and Earned High Impact Factor ONS News; 07/20/2011 The Oncology Nursing Society (ONS) is pleased to announce that the Clinical Journal of Oncology Nursing (CJON), an award-winning publication of ONS, has been accepted for indexing in Web of ScienceSM, the largest and most comprehensive citation index available.
Jill Hamilton, PhD, RN, Receives ONS Publishing Division Award Awards Granted; 07/14/2011 Jill Hamilton, PhD, RN, is the recipient of the Oncology Nursing Society (ONS) Publishing Division’s Excellence in Writing Award for Qualitative Nursing Research.
ONS Receives Awards for Publishing Excellence ONS News; 07/06/2011 The Oncology Nursing Society (ONS) was recently honored with several awards for its publishing excellence.
CDC Releases Report on Colorectal Cancer Legislative Updates; 07/05/2011 The CDC released a report on colorectal cancer with current data on colorectal cancer screening, incidence, and mortality.
Oncology Nursing Society Hosts Meeting of National Healthcare Quality Leaders ONS News; 06/29/2011 As a leading force in the drive to bring the highest quality care to all patients, the Oncology Nursing Society (ONS) hosted a multidisciplinary dialogue on measuring care at its headquarters this week.
FDA Unveils Final Cigarette Warning Labels Legislative Updates; 06/21/2011 The U.S. Food and Drug Administration (FDA) today unveiled the nine graphic health warnings required to appear on every pack of cigarettes sold in the United States and in every cigarette advertisement.
112th Congressional Nursing Caucus Legislative Updates; 06/16/2011 Encourage your representative in Congress to become a member of the House Nursing Caucus.
IOM Releases New Report - Patient-Centered Cancer Treatment Planning Improving the Quality of Oncology Care - Summary of a Workshop Legislative Updates; 06/15/2011 The life-threatening nature of cancer and the complexity of cancer treatment options, each with its own set of potential risks and benefits, make it difficult for people with cancer to make decisions about their care.
The FDA Sheds Light on Sunscreens FDA Updates; 06/15/2011 The Food and Drug Administration (FDA) is taking steps to help protect consumers from skin damage caused by excessive sun exposure.
ONS Submits Formal Testimony Legislative Updates; 06/07/2011 ONS submitted formal testimony to the NIH regarding prescription medication.
Marcelle Kaplan, RN, MS, AOCN®, CBCN®, Chosen 2011 Advanced Oncology Certified Nurse of the Year Awards Granted; 06/03/2011 The Oncology Nursing Certification Corporation (ONCC) has selected Marcelle Kaplan, RN, MS, AOCN®, CBCN® as the 2011 Advanced Oncology Certified Nurse of the Year. Kaplan won the award for her significant contributions to oncology nursing and oncology nursing service and for supporting and promoting certification in oncology nursing.
Maureen O'Hara, RN, MSN, OCN®, Named 2011 Oncology Certified Nurse of the Year Awards Granted; 06/03/2011 The Oncology Nursing Certification Corporation (ONCC) has selected Maureen O’Hara, RN, BSN, OCN® as the 2011 Oncology Certified Nurse of the Year. O’Hara was selected for the award for her contributions to oncology nursing and oncology nursing service and for supporting and promoting certification in oncology nursing.
ONCC Presents Employer Recognition Award Awards Granted; 06/03/2011 The Oncology Nursing Certification Corporation (ONCC) has selected Springfield Oncology Hematology Associates (OHA) in Springfield, MO, as a recipient of its 2011 Employer Recognition Award. Each year this award recognizes one organization that employs less than 25 registered nurses for providing sustained support of oncology nursing certification.
ONCC Presents Second Employer Recognition Award Awards Granted; 06/03/2011 The Oncology Nursing Certification Corporation (ONCC) has selected Georgetown University Hospital, as a recipient of its 2011 Employer Recognition Award. Each year this award recognizes one organization that employs 25 or more registered nurses for their sustained support of oncology nursing certification.
Susan Bowman, RN, OCN, CBCN, MSW Named Certified Breast Care Nurse of the Year Awards Granted; 06/03/2011 The Oncology Nursing Certification Corporation (ONCC) has selected Susan Bowman, RN, OCN®, CBCN®, MSW as the 2011 Certified Breast Care Nurse of the Year.
Laurie Dohnalek, RN, MBA, NE-BC Receives ONS Excellence in Health Policy and Advocacy Award Awards Granted; 05/25/2011 Laurie Dohnalek, RN, MBA, NE-BC, is the recipient of the 2011 Oncology Nursing Society (ONS) Excellence in Oncology Nursing Health Policy and Advocacy Award. This award recognizes and supports her achievements and involvement in oncology nursing health policy and advocacy.
FDA Approves Sunitinib FDA Updates; 05/24/2011 The US Food and Drug Administration approved sunitinib (Sutent® Capsules, Pfizer, Inc.) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in patients with unresectable, locally advanced, or metastatic disease.
Laurie Dohnalek, RN, MBA, NE-BC, Receives ONS Excellence in Oncology Nursing Health Policy and Advocacy Award Legislative Updates; 05/20/2011 ONS Health Policy Director Alec Stone congratulates ONS member and 2011 Advocacy Award winner Laurie J. Dohnalek, RN, MBA, NE-BC after receiving her plaque for outstanding contributions in oncology nursing health policy advocacy.
ONS Signs on to Prevent Healthcare-Associated Infections Legislative Updates; 05/19/2011 The Oncology Nursing Society (ONS) joined the U.S. Department of Health and Human Services along with hospitals, healthcare providers, and other organizations in the Partnership for Patients to make hospital care safer, more reliable, and less costly.
Sebelius Recognizes Nurses for Their Commitment, Leadership, and Vision Legislative Updates; 05/12/2011 Kathleen Sebelius, secretary of the U.S. Department of Health and Human Services, recognized the contributions of nurses and thanked them for their critical work in an official statement released in honor of National Nurses Week.
FDA Approves Everolimus FDA Updates; 05/05/2011 The U.S. Food and Drug Administration approved everolimus (Afinitor® Tablets, Novartis Pharmaceuticals Corporation), for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease.
ONS Signs on Support to Maintain Prevention and Public Health Fund Legislative Updates; 05/04/2011 With the concern about the future implementation of the Patient Protection and Affordable Care Act (PPACA) and the current economic environment, ONS has joined a number of other cancer organizations in raising Congress's awareness of the importance of a key prevention and detection fund included in the original legislation.
ONS Announces 2011-2012 Board of Directors ONS News; 04/30/2011 The Oncology Nursing Society (ONS) announced its 2011–2012 Board of Directors at its 36th Annual Congress in Boston, MA.
ONS Joins Journey Forward Collaborative to Benefit Cancer Survivors ONS News; 04/28/2011 The Oncology Nursing Society (ONS) has joined the Journey Forward collaborative to promote cancer survivorship through the use of Survivorship Care Plans.
Judith Johnson, PhD, RN, FAAN, Receives ONS Lifetime Achievement Award Awards Granted; 04/25/2011 Judith Johnson, PhD, RN, FAAN, is the recipient of the 2011 Oncology Nursing Society (ONS) Lifetime Achievement Award. The award recognizes her outstanding contributions as an oncology nurse researcher, mentor, and educator as well as her service to ONS and the community at large.
Martha Langhorne, MSN, RN, FNP, AOCN®, Receives Pearl Moore Making A Difference Award Awards Granted; 04/25/2011 Martha Langhorne, MSN, RN, FNP, AOCN®, is the 2011 recipient of the Oncology Nursing Society (ONS) Pearl Moore Making a Difference Award. The award recognizes her significant contributions to the oncology nursing profession at the local and regional levels
ONS Hires Executive Director of Professional Practice and Programs ONS News; 04/19/2011 The Oncology Nursing Society (ONS) has hired Elizabeth Wertz Evans, RN, BSN, MPM, FACMPE, CPHQ, CPHIMS, to serve as executive director of professional practice and programs. She will lead ONS’s division that oversees education, publishing, research, library/archives, and international initiatives.
ONS Member Patrick Coyne, MSN, APN, FAAN Testifies Before Congressional Committee on Need for Continued Access to Pain Medication for Patients With Cancer Legislative Updates; 04/14/2011 ONS member Patrick Coyne, MSN, APN, FAAN, was a witness and testified on behalf of the broad patient and provider communities regarding pain relief at a hearing "Warning: The Growing Danger of Prescription Drug Diversion."
FDA Approves Vandetanib Tablets FDA Updates; 04/12/2011 The U. S. Food and Drug Administration approved vandetanib tablets (Vandetanib Tablets, AstraZeneca Pharmaceuticals LP), a kinase inhibitor, for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable, locally advanced, or metastatic disease. The use of vandetanib in patients with indolent, asymptomatic or slowly progressing disease should be carefully considered because of the treatment-related risks of vandetanib.
ONS Board Makes Changes to National Conference Offerings for 2012 ONS News; 04/11/2011 The ONS Board of Directors approved some exciting new changes to ONS’s national conference offerings at its March 2011 meeting. These changes are in direct response to customer feedback and the changing landscape of healthcare meetings and education.
ONS PEP Resources Now Included in National Guidelines ONS News; 04/04/2011 ONS’s Putting Evidence Into Practice (PEP®) guidelines are now included in the National Guideline Clearinghouse (NGC), an initiative of the U.S. Department of Health and Human Services’ Agency for Healthcare Research and Quality (AHRQ).
FDA Approves Peginterferon Alfa-2B FDA Updates; 03/29/2011 The U.S. Food and Drug Administration approved peginterferon alfa-2b (Sylatron™, Schering Corporation, Kenilworth, NJ 07033), for the treatment of patients with melanoma with microscopic or gross nodal involvement within 84 days of definitive surgical resection including complete lymphadenectomy.
FDA Approves Ipilimumab Injection FDA Updates; 03/25/2011 The U. S. Food and Drug Administration approved ipilimumab injection (YERVOY ®, Bristol-Myers Squibb Company) for the treatment of unresectable or metastatic melanoma.
David Makumi-Kinyanjui, RN, MPC(c), Receives ONS International Award Awards Granted; 03/24/2011 David Makumi-Kinyanjui, RN, MPC(c), is the 2011 recipient of the Oncology Nursing Society (ONS) International Award for Contributions to Cancer Care. The award recognizes his contribution in drawing the attention of the country to the cancer crisis and his leadership in empowering nurses and ordinary Kenyans with knowledge and skills to respond to the growing cancer problem.
Donna L. Berry, PhD, RN, AOCN®, FAAN, Receives 2011 Oncology Nursing Society Distinguished Researcher Award Awards Granted; 03/17/2011 Donna L. Berry, PhD, RN, AOCN®, FAAN, has been named the Oncology Nursing Society’s (ONS) 2011 Distinguished Researcher.
Update on the Institute of Medicine Report on the Future of Nursing ONS News; 03/08/2011 The Oncology Nursing Society (ONS) has developed a number of tactics that address the key messages identified in the Institute of Medicine (IOM) Report on the Future of Nursing, which was published in October 2010.
Bakitas Receives ONS 2011 New Investigator Award Awards Granted; 02/12/2011 Marie Anne Bakitas, DNSc, APRN, NP-C, AOCN®, ACHPN, FAAN, was presented the Oncology Nursing Society (ONS) 2011 Victoria Mock New Investigator Award today at the ONS 11th National Conference on Cancer Nursing Research in Los Angeles, CA.
Donald Bailey, Jr., PhD, RN, Presents 2011 Oncology Nursing Society State-of-the-Science Lecture Awards Granted; 02/11/2011 Donald Bailey, Jr., PhD, RN, presented the 2011 Oncology Nursing Society (ONS) State-of-the-Science Lecture, “Illness Uncertainty in Adult Cancer Patients,” today during the ONS 11th National Conference on Cancer Nursing Research in Los Angeles.
Just Being at High Risk for Breast Cancer Is a Life-Changing Experience Press Releases; 02/11/2011 Young African American women at high risk for breast cancer described the risk itself as a life-changing experience, according to a study released today at the Oncology Nursing Society (ONS) 11th National Conference on Cancer Nursing Research.
Study Supports Forgoing Axillary Dissection in Some Patients With Breast Cancer ONS News; 02/11/2011 A study published Wednesday in JAMA found that, among a small subset of patients with breast cancer, axillary dissection in patients with sentinel node metastases does not significantly affect survival rates. The study was covered by the mainstream media with a New York Times’ reporter describing it as turning “standard medical practice on its head.” Although the findings are exciting for breast cancer patients, nurses play a key role in helping patients understand the limitations of the findings.
Whether They Smoke or Not, Patients Say Lung Cancer Diagnosis Carries a Social Stigma Press Releases; 02/11/2011 Patients with lung cancer, whether they smoke or not, feel stigmatized because their disease is strongly associated with smoking, according to a study released today at the Oncology Nursing Society (ONS) 11th National Conference on Cancer Nursing Research.
Study Finds More Survivorship Programs Needed; Time and Funding Present the Greatest Barriers ONS News; 02/08/2011 An estimated 12 million people are cancer survivors, yet only 27% of nurses working in oncology report that their practice has a formal survivorship program.
FDA Approves Rituximab FDA Updates; 01/28/2011 the U.S. Food and Drug Administration approved rituximab (Rituxan®, Genentech, Inc) for maintenance therapy for patients with previously untreated follicular, CD-20 positive, B-cell non-Hodgkin lymphoma who achieve a response to rituximab in combination with chemotherapy.
ONS Partners With Advocacy Groups for Ice Skating Spectacular ONS News; 12/17/2010 The Oncology Nursing Society (ONS) has joined leading cancer advocacy groups and professional associations to support an education and awareness platform around cancer survivorship through a holiday television special called Kaleidoscope on Ice.
LDI on Hold for 2011 ONS News; 12/08/2010 For many years, the ONS Leadership Development Institute (LDI) has brought together hundreds of participants from a variety of backgrounds for a three-day leadership conference followed by a year of mentorship and goal accomplishment. Due to changing needs, the decision has been made to take a step back from our current LDI program in 2011 and allow for a period of assessment and reflection. Therefore, ONS will not offer LDI in 2011. We look forward to a continued tradition of excellence in leadership programming that will address the needs of nurses in the future.
One Nurse is Special to Many ONS News; 12/08/2010 Of all the nominations received for Honor Someone Special, no one has been named more than Mary Diffendall, RN, OCN®. Mary, an oncology nurse at Connecticut Oncology Group in Middletown, has been nominated for Honor Someone Special 26 times, often by her patients. Here is what is being said about Mary.
FDA Approves Denosumab FDA Updates; 11/18/2010 The U.S. Food and Drug Administration granted approval for denosumab (Xgeva™, Amgen Inc.) for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors. Denosumab is not indicated for the prevention of SREs in patients with multiple myeloma.
FDA Grants Approval for Eribulin Mesylate FDA Updates; 11/15/2010 The US Food and Drug Administration granted approval for eribulin mesylate (Halaven™ Injection, Eisai Inc.) for the treatment of patients with metastatic breast cancer who have previously received an anthracycline and a taxane in either the adjuvant or metastatic setting, and at least two chemotherapeutic regimens for the treatment of metastatic disease.
Labeling Changes Regarding Safety Information for Trastuzumab FDA Updates; 11/02/2010 This notice is to inform you of important new safety information regarding the already labeled adverse reaction of oligohydramnios (decreased amniotic fluid).
FDA Grants Accelerated Approval to Everolimus FDA Updates; 10/29/2010 the U.S. Food and Drug Administration granted accelerated approval to everolimus (Afinitor®, Novartis), an mTOR inhibitor, for patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS) who require therapy but are not candidates for surgical resection.
ONS Secures New Tenant ONS News; 10/29/2010 Industrial Scientific Corporation has signed a lease with the Oncology Nursing Society (ONS) in RIDC Park West. The 35,000-square foot Findlay Township location will serve as their primary development and commercial facility. The company’s corporate headquarters is located in Oakdale.
FDA Grants Accelerated Approval to Dasatinib FDA Updates; 10/28/2010 The U.S. Food and Drug Administration granted accelerated approval to dasatinib [Sprycel®, Bristol-Myers Squibb], an orally administered kinase inhibitor, for the treatment of newly diagnosed adult patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase (CP-CML).
FDA Grants Approval for Trastuzumab in Combination With Other Drugs FDA Updates; 10/20/2010 The US Food and Drug Administration granted approval for trastuzumab (Herceptin®), Genentech, Inc.), in combination with cisplatin and a fluoropyrimidine (capecitabine or 5-fluorouracil), for the treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal (GE) junction adenocarcinoma, who have not received prior treatment for metastatic disease.
White House Goes Pink to Raise Awareness for Breast Cancer Legislative Updates; 10/14/2010 At 6:30 pm October 14, the White House was bathed in a soft pink light to make a public statement about breast cancer awareness month.
Changes in Measurement of Serum Creatinine May Impact Carboplatin Dosing FDA Updates; 10/08/2010 Recent changes in the measurement of serum creatinine may have an impact on carboplatin dosing.
Call for NIWI Applicants Legislative Updates; 10/07/2010 The Nurse in Washington Internship (NIWI) Program is an annual event sponsored by the Nursing Organizations Alliance (The Alliance). With over 60 member organizations, ONS among them, The Alliance represents approximately 500,000 nurses. The Alliance sponsors the internship to promote the interests of its member groups through education, research, and health-policy activities. Over the years, more than one thousand nurses have attended NIWI, many of whom have become influential participants in the political process at state and federal levels.
ONS Applauds IOM Report on the Future of Nursing Legislative Updates; 10/07/2010 The Institute of Medicine’s latest consensus report on the “The Future of Nursing: Leading Change, Advancing Health” provides support for the crucial role of nursing in addressing the increased demand for services expected from healthcare reform legislation.
Cindy Tofthagen, PhD, ARNP, AOCNP, Receives ONS Foundation Research Fellowship Awards Granted; 09/30/2010
ONS Receives Website Honors Press Releases; 09/30/2010 The Oncology Nursing Society (ONS) was honored by the Web Marketing Association with awards for their website excellence.
Three ONS Members Named Among Top 10 Influential Nursing Professors Press Releases; 09/24/2010 PITTSBURGH, PA – September 24, 2010 – Three ONS members have been named to the list of the top 10 most influential nursing professors by the Mister Medicine blog.
HRSA Study Finds Nursing Workforce is Growing Legislative Updates; 09/22/2010 The Health Resources and Services Administration (HRSA) recently presented a report showing that the nursing workforce increased by more than 5% between 2004 and 2008.
Johanns' Amendment Rejected by US Senate Legislative Updates; 09/13/2010 The United States Senate rejected Senator Mike Johanns’ (R-NE) amendment to the Small Business Jobs and Credit Act.
ONS Prepares for Fall Conferences ONS News; 08/12/2010 ONS prepares for the 11th Annual Institutes of Learning and ONS Advanced Practice Nursing Conferences in Orlando.
Oncology Nursing Society Sponsors the Institute of Medicine’s National Cancer Policy Forum Press Releases; 07/30/2010 PITTSBURGH, PA – July 30, 2010 – The Oncology Nursing Society (ONS) is pleased to announce its sponsorship of the Institute of Medicine’s (IOM) National Cancer Policy Forum. The Forum explores emerging policy issues in the nation’s effort to combat cancer and enables all members to be full participants in identifying and debating critical issues and examining potential actions.
ONS President Addresses FDA Legislative Updates; 07/26/2010 PITTSBURGH, PA – July 26, 2010 – Oncology Nursing Society (ONS) President Carlton Brown, RN, PhD, AOCN®, testified before a U.S. Food and Drug Administration (FDA) committee in Washington, DC, regarding the proposed Risk Evaluation and Mitigation Strategies (REMS) for Extended-Release and Long-Acting Opioid Analgesics, which seeks to address the issue of opioid misuse and abuse. The CoC has replied to the letter, indicating that it intends to take some of ONS’s suggestions.
Healthcare Reform: What Does it Mean to You and Your Patients? Legislative Updates; 07/17/2010 View slide presentation from the 2010 ONS Mentorship session.
ONS Celebrates Milestone Press Releases; 07/02/2010 PITTSBURGH, PA – July 2, 2010 – The Oncology Nursing Society (ONS) is celebrating its 35th anniversary as a professional association providing membership benefits to more than 36,000 registered nurses who specialize in caring for patients with cancer.
Pfizer Inc. Announces that Commercial Marketing of Mylotarg (gemtuzumab ozogamicin) Will be Voluntarily Discontinued and the New Drug Application for Mylotarg Will be Withdrawn as of October 15, 2010. FDA Updates; 06/21/2010 On June 21, 2010, Pfizer Inc., in agreement with the FDA, announced that the commercial marketing of Mylotarg (gemtuzumab ozogamicin) will be voluntarily discontinued, and the new drug application (NDA) for Mylotarg will be withdrawn as of October 15, 2010.
FDA Approves Cabazitaxel FDA Updates; 06/17/2010 On June 17, 2010, the U.S. Food and Drug Administration (FDA) approved cabazitaxel (Jevtana® Injection, sanofi-aventis) for use in combination with prednisone for treatment of patients with metastatic hormone-refractory prostate cancer (mHRPC) previously treated with a docetaxel-containing regimen.
FDA Grants Accelerated Approval to Nilotinib FDA Updates; 06/17/2010 On June 17, 2010, the U. S. Food and Drug Administration granted accelerated approval to nilotinib (Tasigna® Capsules, Novartis Pharmaceuticals Corporation), an orally administered kinase inhibitor, for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP-CML).
ONS Awarded for Publishing Excellence Press Releases; 06/15/2010 PITTSBURGH, PA – June 15, 2010 – The Oncology Nursing Society (ONS) was honored by the Association Media and Publishing as a winner of the esteemed EXCEL Award in two categories at its recent 30th Annual EXCEL Awards Gala in Washington, DC.
ONS Provides Key Nursing Resources to Support Cancer Clinical Trials Recommendations ONS News; 05/28/2010 The Oncology Nursing Society’s (ONS’s) long-standing efforts to support clinical trials funding and access to participation are in line with recommendations offered in the Institute of Medicine’s (IOM’s) recent report on the Cooperative Group Program and the American Society of Clinical Oncology’s (ASCO’s) response to the report.
New bill delays medicare pay cut until 2014, provides raises in interim. Legislative Updates; 05/20/2010 Congressional Democrats today unveiled the outline of a bill that would delay a 21% cut in Medicare reimbursement to physicians until 2014 and increase rates for the rest of 2010 as well as 2011.
ONS Announces 2010–2011 Board of Directors Press Releases; 05/15/2010 SAN DIEGO, CA – May 15, 2010 – The Oncology Nursing Society (ONS) announced its 2010–2011 Board of Directors at its 35th Annual Congress in San Diego, CA.
Connie Henke Yarbro, MS, RN, FAAN, Receives 2010 Oncology Nursing Society Lifetime Achievement Award Awards Granted; 05/13/2010 SAN DIEGO, CA – May 13, 2010 – Connie Henke Yarbro, MS, RN, FAAN, of Destin, FL, is the recipient of the 2010 Oncology Nursing Society (ONS) Lifetime Achievement Award. Yarbro is the editor of Seminars in Oncology Nursing and an adjunct clinical associate professor at the University of Missouri-Columbia Sinclair School of Nursing. The award, presented today at the ONS 35th Annual Congress held in San Diego, CA, recognizes her outstanding contributions as an oncology nurse researcher, mentor, and educator as well as her service to ONS and the community at large.
Oncology Nursing and Social Work Professional Associations Press Releases; 04/13/2010 PITTSBURGH, PA – April 13, 2010 – The Oncology Nursing Society (ONS), the Association of Oncology Social Work (AOSW), and the National Association of Social Workers (NASW) worked together to develop a joint position statement on the role of oncology nursing and oncology social work in patient navigation.
New ESA Risk Management System Legislative Updates; 02/16/2010
ONS Joins the Nursing Community to Advocate for Nursing Provisions Legislative Updates; 01/06/2010 ONS joined with others in the nursing community to advocate for nursing provisions.
ONS Members Attend White House Briefing Legislative Updates; 09/10/2009
ONS Written Comments to the FDA Legislative Updates; 06/26/2009 ONS submitted written comments to the Food and Drug Administration (FDA) related to the possibility that the FDA will create a Risk Evaluation and Mitigation Strategies (REMS) for certain opioid drugs.
ONS Testimony for FDA Public Opioid REMS Meeting Legislative Updates; 05/27/2009 This is a synopsis of the testimony ONS delivered to the FDA on May 27th, 2009.
Commitment to Quality Health Reform Legislative Updates; 05/01/2009 Commitment to Quality Health Reform: A Consensus Statement from the Nursing Community
Health Policy Update April 2009 Legislative Updates; 04/01/2009 Health Policy Update April 2009
Cancer and Nursing in the Stimulus Package Legislative Updates; 02/17/2009 President Obama signed the economic stimulus bill (H.R. 1) into law.
ONS Helps Secure Expanded Medicare Off-Label Coverage for Anticancer Therapies Legislative Updates; 01/15/2009 Congress and the Centers for Medicare and Medicaid Services (CMS) took action to expand off-label cancer therapy coverage for Medicare beneficiaries
Role of the Oncology RN in Outpatient Medical Oncology Legislative Updates; 01/02/2009 ONS and US Oncology joined together to develop publication.

Patricia Frank, RN, BSN, Receives 2012 ONS Emerging Leader Award

Awards Granted; 05/18/2012

Patricia Frank, RN, BSN, is the recipient of the 2012 Oncology Nursing Society (ONS) Pearl Moore “Making a Difference” Emerging Leader Award. This award recognizes her as an emerging oncology nurse leader who has made a difference in the oncology nursing profession at the local or regional level.

Anna Schwartz, PhD, FNP, FAAN, Receives 2012 ONS Distinguished Contribution to Nursing Literature Award

Awards Granted; 05/16/2012

Anna Schwartz, PhD, FNP, FAAN, of Wilson, WY, associate professor at Idaho State University in Pocatello and affiliate professor at the University of Washington in Seattle, is the recipient of the Oncology Nursing Society (ONS) 2012 Rose Mary Carroll-Johnson Distinguished Award for Consistent Contribution to the Nursing Literature.

Laura Wood, RN, MSN, OCN®, Presents 2012 ONS Clinical Lecture

Awards Granted; 05/16/2012

Laura Wood, RN, MSN, OCN®, presented the 2012 Oncology Nursing Society (ONS) Clinical Lecture at the ONS 37th Annual Congress which was held May 3-6 in New Orleans, LA.

Kelly Smith, MSN, RN, NP, AOCN, Named 2012 Advanced Oncology Certified Nurse of the Year

Awards Granted; 05/11/2012

The Oncology Nursing Certification Corporation (ONCC) has selected Kelly Smith, MSN, RN, NP, AOCN® as the 2012 Advanced Oncology Certified Nurse of the Year. Smith was selected for the award for her contributions to oncology nursing and oncology nursing service; and for supporting and promoting certification in oncology nursing.

ONCC Honors Froedtert Hospital

Awards Granted; 05/11/2012

The Oncology Nursing Certification Corporation (ONCC) has named Froedtert Hospital in Milwaukee, WI, as a recipient of its 2012 Employer Recognition Award. Each year, this award recognizes one institution that employs 25 or more registered nurses for providing sustained support of oncology nursing certification.

ONCC Honors Moncrief Cancer Institute

Awards Granted; 05/11/2012

The Oncology Nursing Certification Corporation (ONCC) has selected Moncrief Cancer Institute in Fort Worth, TX, as a recipient of its 2012 Employer Recognition Award. Each year, this award recognizes one organization that employs less than 25 registered nurses for providing sustained support of certification in oncology nursing.

Sylvia Danko, RN, BSN, OCN, CBCN, Named 2012 Oncology Certified Nurse of the Year

Awards Granted; 05/11/2012

The Oncology Nursing Certification Corporation (ONCC) has selected Sylvia Danko, RN, BSN, OCN®, CBCN® as the 2012 Oncology Certified Nurse of the Year. Danko was selected for the award for her contributions to oncology nursing and oncology nursing service, and for supporting and promoting certification in oncology nursing.

FDA Approves Pazopanib Tablets

FDA Updates; 04/26/2012

The U.S. Food and Drug Administration approved pazopanib tablets (VOTRIENT®, a registered Trademark of GlaxoSmithKline) for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy.

FDA Grants Approval to Everolimus

FDA Updates; 04/26/2012

The U.S. Food and Drug Administration granted accelerated approval to everolimus (Afinitor tablets, Novartis) for the treatment of adults with renal angiomyolipoma, associated with tuberous sclerosis complex (TSC), who do not require immediate surgery.

The Regional Cancer Center Receives ONS Employer Recognition Award

Awards Granted; 04/18/2012

The Oncology Nursing Society (ONS) has selected The Regional Cancer Center (RCC) in Erie, PA, as the recipient of its 2012 Employer Recognition Award for medium-sized employers. This award recognizes employers who show exemplary support of their registered nurses working in oncology. The award will be presented during ONS’s 37th Annual Congress in New Orleans, LA, on May 3–6.

Report Outlines Innovative Breast Cancer Rehabilitation Model

ONS News; 04/11/2012

The Oncology Nursing Society (ONS) is proud to be part of an international initiative that outlines an innovative model to address a wide range of physical issues faced by women with breast cancer and offers hope for improved function and full participation in life activities for patients through rehabilitation and exercise.

Carol Reed Ash, EdD, RN, FAAN, Receives 2012 ONS Lifetime Achievement Award

Awards Granted; 04/05/2012

Carol Reed Ash, EdD, RN, FAAN, is the recipient of the 2012 Oncology Nursing Society (ONS) Lifetime Achievement Award. Ash is professor emeritus, Kirbo Endowed Chair, Oncology Nursing at the University of Florida in Gainesville. The award recognizes her outstanding contributions as an oncology nurse researcher, mentor, and educator as well as her service to ONS and the community at large.

Donna Berry, PhD, RN, AOCN®, FAAN, Receives ONS Foundation Research Grant Award

Awards Granted; 03/22/2012

Donna Berry, PhD, RN, AOCN®, FAAN, is the recipient of an ONS Foundation Endowment Nursing Research Grant for her project entitled, “ESRA-C Spanish: Linguistic Appropriateness and Cultural Sensitivity.”

Release of USPSTF Final Recommendation on Screening for Cervical Cancer

Legislative Updates; 03/16/2012

Today, the U.S. Preventive Services Task Force posted its final recommendation statement on screening for cervical cancer.

March is National Colorectal Cancer Awareness Month

Legislative Updates; 03/09/2012

CMS Offers Insight to Colorectal Cancer Awareness Month in March. Of cancers that affect both men and women, colorectal cancer is the second leading cause of cancer-related deaths in the United States and the third most common cancer in men and in women.

ONS Releases Position on Lifelong Learning

ONS News; 03/09/2012

Cancer care is rapidly changing, and nurses who care for patients with cancer must commit to lifelong learning to have the expert skills and knowledge they need to provide quality cancer care to their patients. The Oncology Nursing Society (ONS) has released a new position statement on this topic.

FDA’s graphic labeling of tobacco products

Legislative Updates; 03/02/2012

On February 29, DC District Judge Richard Leon overturned a lower Court’s decision allowing the FDA’s graphic labeling of tobacco products.

ONS Presents Employer Recognition Award to Moffitt Cancer Center

Awards Granted; 03/01/2012

The Oncology Nursing Society (ONS) has selected Moffitt Cancer Center in Tampa, FL, as the recipient of its 2012 Employer Recognition Award for large employers.

ONCC Receives Accreditation of CPHON® Certification

ONS News; 02/22/2012

The Oncology Nursing Certification Corporation (ONCC) received accreditation of its Certified Pediatric Hematology Oncology Nurse (CPHON®) program from the National Commission for Certifying Agencies (NCCA). The accreditation is valid through April 30, 2015.

FDA Announces Action to Bolster Supply of Doxil and Methotrexate

FDA Updates; 02/21/2012

The FDA announces major actions taken to bolster the supply of Doxil® (Janssen Research & Development LLC.) and preservative-free formulations of methotrexate.

ONS Partners With Congressman to Reintroduce Legislation

ONS News; 02/21/2012

The Oncology Nursing Society (ONS) with Representative Steve Israel (D-NY) announced today the unveiling of his legislation, HR 3790, “The Improving Cancer Treatment Education Act of 2012.” The announcement was made at a special event at Huntington Hospital in Long Island, NY.

ONS Honored with Publishing PROSE Award

ONS News; 02/13/2012

ONS's award-winning publishing division is pleased to announce that it has received an award from the Professional and Scholarly Publishing Division of the Association of American Publishers.

FDA Grants Regular Approval for Imatinib Mesylate Tablets

FDA Updates; 01/31/2012

The U.S. Food and Drug Administration (FDA) granted regular approval for imatinib mesylate tablets (Gleevec®, Novartis Pharmaceuticals) for the adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive Gastrointestinal Stromal Tumors (GIST).

The FDA Approves Vismodegib for Metastatic Basal Cell Carcinoma

FDA Updates; 01/30/2012

The U.S. Food and Drug Administration approved vismodegib (ERIVEDGE™ Capsule, Genentech, Inc.) for the treatment of adults with metastatic basal cell carcinoma or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery, and who are not candidates for radiation.

FDA Approves Axitinib Tablets for Advanced Renal Cell Carcinoma

FDA Updates; 01/27/2012

The U.S. Food and Drug Administration approved axitinib tablets (Inlyta, Pfizer, Inc.) for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy.

ONS Wins 2011 AJN Book of the Year Award

ONS News; 01/26/2012

The American Journal of Nursing (AJN) has awarded the prestigious 2011 AJN Book of the Year Award to the Oncology Nursing Society (ONS) for Advanced Oncology Nursing Certification Review and Resource Manual: Instructor’s Resource, edited by Shirley Triest-Robinson, RN, PhD, AOCNS®, ACNS B, and Wendy H. Vogel, MSN, FNP, AOCNP®, in the Electronic Media category.

Oncology Nursing Society Announces Anne Katz as Oncology Nursing Forum Editor

ONS News; 01/25/2012

The Oncology Nursing Society (ONS) is pleased to announce Anne Katz, RN, PhD, as the new editor of the Oncology Nursing Forum (ONF), the Society’s flagship journal. Katz will begin her new responsibility on March 1.

United States Senate Passes a Resolution Recognizing the 40th Anniversary of the National Cancer Act

Legislative Updates; 01/19/2012

A resolution recognizing the 40th anniversary of the National Cancer Act of 1971 and the more than 12,000,000 survivors of cancer alive today because of the commitment of the United States to cancer research and advances in cancer prevention, detection, diagnosis, and treatment.

FDA Approves Glucarpidase Injection

FDA Updates; 01/17/2012

The US Food and Drug Administration approved glucarpidase injection (Voraxaze®, BTG International Inc.) for the treatment of toxic plasma methotrexate concentrations (> 1 µmol/L) in patients with delayed methotrexate clearance due to impaired renal function.

FDA Approves Changes to Methotrexate Package Insert

FDA Updates; 12/21/2011

The US Food and Drug Administration has approved changes to the package inserts for methotrexate products for intravenous administration.

ONS Hosts Health Information Technology Think Tank

ONS News; 12/15/2011

The Oncology Nursing Society (ONS) recently hosted a groundbreaking HIT Think Tank in Pittsburgh, PA, to assess ways to support their members as HIT becomes more a part of everyday life in healthcare organizations.

ONS Congratulates Lt. General Horoho

Legislative Updates; 12/14/2011

ONS congratulates Lt. General Horoho on her confirmation as the newest Surgeon General of the US Army.

ONCC Announces Innovative Renewal Method for Certified Nurses

ONS News; 12/09/2011

Nurses who are certified by the Oncology Nursing Certification Corporation (ONCC) will soon have a new method for renewing their certification credentials.

US Senate Finance Committee Holds Hearing on National Drug Shortage

Legislative Updates; 12/07/2011

The US Senate Finance Committee holds hearing on the national drug shortage.

FDA Approves Changes to REMS for Romiplostim and Eltrombopag

FDA Updates; 12/06/2011

The Food and Drug Administration (FDA) approved changes to the Risk Evaluation and Mitigation Strategies (REMS) for romiplostim (Nplate for subcutaneous injection, Amgen Inc.) and eltrombopag (Promacta tablets, GlaxoSmithKline LLC) to remove the restricted distribution programs and the safety reporting requirements that were part of the REMS. Prescriber, institution, pharmacy, and patient enrollment and these data collection requirements are no longer necessary.

NCI Launches Smoking Cessation Support for Teens

Legislative Updates; 12/05/2011

A new effort to help teens quit smoking will use one of today's teen's most constant companions - the mobile phone. Developed by smoking cessation experts, SmokefreeTXT is a free text message cessation service that provides 24/7 encouragement, advice, and tips to teens trying to quit smoking.

New Breast Cancer Survivor Research Underscores Need for Quality Measures

ONS News; 11/22/2011

The ONS Foundation and the Cancer Support Community (CSC) are advancing the understanding of the needs of, and treatment for, breast cancer survivors through two multi-year projects, both funded by The Breast Cancer Fund of National Philanthropic Trust starting in 2009.

FDA Approves Asparaginase Erwinia Chrysanthemi for ALL

FDA Updates; 11/18/2011

The US Food and Drug Administration approved asparaginase Erwinia chrysanthemi [ErwinazeTM, injection, EUSA Pharma (USA), Inc.] as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.

President Obama: Great American Smokeout

Legislative Updates; 11/18/2011

President Obama: Congratulations to Everyone Taking Part in Today's Great American Smokeout.

FDA Approves Ruxolitinib (Jakafi oral tablets, Incyte Corporation) for the treatment of intermediate and high risk myelofibrosis

FDA Updates; 11/16/2011

The US Food and Drug Administration approved ruxolitinib (Jakafi oral tablets, Incyte Corporation) for the treatment of intermediate and high risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis.

FDA Approves Cetuximab

FDA Updates; 11/07/2011

The US Food and Drug Administration approved cetuximab (Erbitux®, ImClone LLC, a wholly-owned subsidiary of Eli-Lilly and Company) in combination with platinum-based therapy plus 5-florouracil (5-FU) for the first-line treatment of patients with recurrent locoregional disease and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).

NIH Researchers Design Light Therapy

Legislative Updates; 11/07/2011

NIH researchers created a light-based therapy that targets and destroys certain tumors and cancers in mice, according to the NCI.

ONS Announces Updates to its Research Agenda

ONS News; 10/28/2011

The Oncology Nursing Society (ONS) announces that its Research Agenda, which focuses on gaps in the knowledge base for oncology nursing practice, was updated in 2011.

ONS Collaborates with CDC to Develop an Infection Control and Prevention Plan for Outpatient Oncology Services

ONS News; 10/25/2011

The CDC has released a new program called Preventing Infections in Cancer Patients. The program consists of two new tools for patients, their caregivers, and their healthcare providers.

CDC Releases Most Comprehensive Melanoma Report in the US to Date

Legislative Updates; 10/19/2011

Melanoma skin cancer has a costly and deadly impact on America. The CDC releases the most comprehensive melanoma report in the United States to date.

FDA Grants Accelerated Approval to Deferiprone

FDA Updates; 10/14/2011

The US Food and Drug Administration granted accelerated approval to deferiprone (Ferriprox® Tablets, ApoPharma, Inc.), an oral iron chelator for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.

Breast Cancer Awareness Month

Legislative Updates; 10/06/2011

Read a statement from Secretary Sebilius about National Breast Cancer Awareness Month.

White House Goes Pink

Legislative Updates; 10/06/2011

October is National Breast Cancer Awareness Month – a time to remember those who have lost their lives to breast cancer and those who are battling it now, and to celebrate with those who have survived. It is also a time to reaffirm our commitment to fighting breast cancer and to remind ourselves of the importance of prevention and early detection.

Changes in Bevacizumab Package Insert

FDA Updates; 10/03/2011

Changes in bevacizumab (Avastin®, Genentech, Inc.) package insert regarding: risk of ovarian failure, osteonecrosis of the jaw, risk of venous thromboembolic event (VTE) and bleeding in patients receiving anticoagulation therapy after first VTE event.

FDA Grants Accelerated Approval for Eculizumab

FDA Updates; 09/23/2011

the U.S. Food and Drug Administration (FDA) granted accelerated approval for the use of eculizumab (Soliris®, Alexion, Inc.) for the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS).

New Guiding Principles Will Protect ONS's Integrity and Reputation

ONS News; 09/20/2011

The ONS Board of Directors approved a new set of guiding principles for corporate support and conflicts of interest (COIs) that is designed to provide a framework for relationships and interactions between ONS and for-profit organizations.

ONS Board Announces 2012-2016 Strategic Plan

ONS News; 09/20/2011

After conducting a thorough scan of the oncology healthcare environment, the Oncology Nursing Society (ONS) developed a new five-year strategic plan, which will take effect in 2012.

ONS Overhauls Position Statement Program to Better Address Current Cancer Care Environment

ONS News; 09/20/2011

During its July 2011 Board meeting, the ONS Board of Directors conducted a thorough review of Society’s current position statements and noted that some of the current positions no longer speak to a perspective unique to ONS, may no longer be relevant, or are now common practice. As a result, some positions will be revised, some will be combined together and retitled, and others will be archived as they currently stand, with possible key components incorporated into other positions as applicable.

ONS Revamps Approach to Leadership Development

ONS News; 09/20/2011

The ONS Leadership Development Institute (LDI) was held annually from 1998–2010. Although the program was well received, the number of nurses participating was limited each year. In response to the current economic climate, the ONS Board of Directors and staff decided to step back and re-evaluate the program, as well as define the leadership needs of the ONS membership and the organization as a whole.

FDA Grants Approval for Denosumab

FDA Updates; 09/16/2011

The US Food and Drug Administration granted approval for denosumab (Prolia®, Amgen Inc.) as a treatment to increase bone mass in patients at high risk for fracture receiving androgen deprivation therapy (ADT) for nonmetastatic prostate cancer or adjuvant aromatase inhibitor (AI) therapy for breast cancer. In men with nonmetastatic prostate cancer, denosumab also reduced the incidence of vertebral fracture.

Patient Navigation Supplement Cosponsored by ONS is Published

ONS News; 09/16/2011

Together with the American Cancer Society, ONS cosponsored a special supplement that focuses on the importance of patient navigation.

Lung Cancer Rates Decline Nationnwide

Legislative Updates; 09/15/2011

A new report shows a continuing decline in rates of new lung cancer cases among men, and a promising decline among women.

ONS Hosts First All-Virtual Conference

ONS News; 09/12/2011

Nurses from across the country gathered for the Oncology Nursing Society’s (ONS) Radiation eConference: Radiation Then and Now, and they never had to leave their hometowns. The Radiation eConference is ONS’s first all virtual event.

CDC Releases New Report on Smoking

Legislative Updates; 09/07/2011

The CDC releases a new report on smoking. While heavy smoking decreases, light smoking increases.

ONS Offers Resources for Safe Handling of Chemotherapy

ONS News; 09/07/2011

Unintentional exposure to hazardous agents such as chemotherapy may endanger the lives of healthcare workers. The Oncology Nursing Society (ONS) offers resources designed to educate nurses on safe handling procedures.

Call for Nurse in Washington Internship Applicants

ONS News; 09/02/2011

The Nurse in Washington Internship (NIWI) Program is an annual event sponsored by the Nursing Organizations Alliance. The purpose of the NIWI Program is to provide nurses the opportunity to learn how to influence health care through legislative and regulatory processes. Participants learn from health policy experts and government officials and network with other nurses. The next NIWI is scheduled to be held February 26–28, 2012, in Washington, DC. This year, ONS is offering a limited number of grants for nurses to attend NIWI. The deadline to apply for the grant is November 1, 2011. Recipients of the grants will receive full registration for NIWI, expenses for travel and hotel, and a per diem.

NIH-Funded Researchers Discover Genetic Link to Mesothelioma

Legislative Updates; 08/29/2011

Scientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer -- mesothelioma, and melanoma of the eye. Additionally, when these individuals are exposed to asbestos or similar mineral fibers, their risk of developing mesothelioma, an aggressive cancer of the lining of the chest and abdomen, may be markedly increased

FDA Grants Accelerated Approval to Crizotinib

FDA Updates; 08/26/2011

The US Food and Drug Administration granted accelerated approval to crizotinib (XALKORI® Capsules, Pfizer Inc.) for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.

FDA Grants Accelerated Approval to Brentuximab Vedotin

FDA Updates; 08/19/2011

The US Food and Drug Administration granted accelerated approval to brentuximab vedotin (Adcetris™ for Injection, Seattle Genetics, Inc.) for two indications: • The treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates. • The treatment of patients with systemic anaplastic large cell lymphoma (ALCL) after failure of at least one prior multi-agent chemotherapy regimen.

FDA Approves Vemurafenib Tablets

FDA Updates; 08/17/2011

The US Food and Drug Administration approved vemurafenib tablets (ZELBORAFTM, Hoffmann-La Roche Inc.) for the treatment of patients with unresectable or metastatic melanoma with the BRAFV600E mutation as detected by an FDA-approved test.

NIH Releases Study Implicating Cigarette Smoking in Half of Bladder Cancers in Women

Legislative Updates; 08/16/2011

NIH study confirms bladder cancer risk from smoking is higher than previously estimated.

HHS Awards $71.3 Million to Strengthen Nursing Workforce

Legislative Updates; 07/29/2011

The Department of Health and Human Services announces $71.3 million in nursing workforce grants to support training, diversity, and nursing faculty.

ONS Journal CJON Accepted for Indexing and Earned High Impact Factor

ONS News; 07/20/2011

The Oncology Nursing Society (ONS) is pleased to announce that the Clinical Journal of Oncology Nursing (CJON), an award-winning publication of ONS, has been accepted for indexing in Web of ScienceSM, the largest and most comprehensive citation index available.

Jill Hamilton, PhD, RN, Receives ONS Publishing Division Award

Awards Granted; 07/14/2011

Jill Hamilton, PhD, RN, is the recipient of the Oncology Nursing Society (ONS) Publishing Division’s Excellence in Writing Award for Qualitative Nursing Research.

ONS Receives Awards for Publishing Excellence

ONS News; 07/06/2011

The Oncology Nursing Society (ONS) was recently honored with several awards for its publishing excellence.

CDC Releases Report on Colorectal Cancer

Legislative Updates; 07/05/2011

The CDC released a report on colorectal cancer with current data on colorectal cancer screening, incidence, and mortality.

Oncology Nursing Society Hosts Meeting of National Healthcare Quality Leaders

ONS News; 06/29/2011

As a leading force in the drive to bring the highest quality care to all patients, the Oncology Nursing Society (ONS) hosted a multidisciplinary dialogue on measuring care at its headquarters this week.

FDA Unveils Final Cigarette Warning Labels

Legislative Updates; 06/21/2011

The U.S. Food and Drug Administration (FDA) today unveiled the nine graphic health warnings required to appear on every pack of cigarettes sold in the United States and in every cigarette advertisement.

112th Congressional Nursing Caucus

Legislative Updates; 06/16/2011

Encourage your representative in Congress to become a member of the House Nursing Caucus.

IOM Releases New Report - Patient-Centered Cancer Treatment Planning Improving the Quality of Oncology Care - Summary of a Workshop

Legislative Updates; 06/15/2011

The life-threatening nature of cancer and the complexity of cancer treatment options, each with its own set of potential risks and benefits, make it difficult for people with cancer to make decisions about their care.

The FDA Sheds Light on Sunscreens

FDA Updates; 06/15/2011

The Food and Drug Administration (FDA) is taking steps to help protect consumers from skin damage caused by excessive sun exposure.

ONS Submits Formal Testimony

Legislative Updates; 06/07/2011

ONS submitted formal testimony to the NIH regarding prescription medication.

Marcelle Kaplan, RN, MS, AOCN®, CBCN®, Chosen 2011 Advanced Oncology Certified Nurse of the Year

Awards Granted; 06/03/2011

The Oncology Nursing Certification Corporation (ONCC) has selected Marcelle Kaplan, RN, MS, AOCN®, CBCN® as the 2011 Advanced Oncology Certified Nurse of the Year. Kaplan won the award for her significant contributions to oncology nursing and oncology nursing service and for supporting and promoting certification in oncology nursing.

Maureen O'Hara, RN, MSN, OCN®, Named 2011 Oncology Certified Nurse of the Year

Awards Granted; 06/03/2011

The Oncology Nursing Certification Corporation (ONCC) has selected Maureen O’Hara, RN, BSN, OCN® as the 2011 Oncology Certified Nurse of the Year. O’Hara was selected for the award for her contributions to oncology nursing and oncology nursing service and for supporting and promoting certification in oncology nursing.

ONCC Presents Employer Recognition Award

Awards Granted; 06/03/2011

The Oncology Nursing Certification Corporation (ONCC) has selected Springfield Oncology Hematology Associates (OHA) in Springfield, MO, as a recipient of its 2011 Employer Recognition Award. Each year this award recognizes one organization that employs less than 25 registered nurses for providing sustained support of oncology nursing certification.

ONCC Presents Second Employer Recognition Award

Awards Granted; 06/03/2011

The Oncology Nursing Certification Corporation (ONCC) has selected Georgetown University Hospital, as a recipient of its 2011 Employer Recognition Award. Each year this award recognizes one organization that employs 25 or more registered nurses for their sustained support of oncology nursing certification.

Susan Bowman, RN, OCN, CBCN, MSW Named Certified Breast Care Nurse of the Year

Awards Granted; 06/03/2011

The Oncology Nursing Certification Corporation (ONCC) has selected Susan Bowman, RN, OCN®, CBCN®, MSW as the 2011 Certified Breast Care Nurse of the Year.

Laurie Dohnalek, RN, MBA, NE-BC Receives ONS Excellence in Health Policy and Advocacy Award

Awards Granted; 05/25/2011

Laurie Dohnalek, RN, MBA, NE-BC, is the recipient of the 2011 Oncology Nursing Society (ONS) Excellence in Oncology Nursing Health Policy and Advocacy Award. This award recognizes and supports her achievements and involvement in oncology nursing health policy and advocacy.

FDA Approves Sunitinib

FDA Updates; 05/24/2011

The US Food and Drug Administration approved sunitinib (Sutent® Capsules, Pfizer, Inc.) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in patients with unresectable, locally advanced, or metastatic disease.

Laurie Dohnalek, RN, MBA, NE-BC, Receives ONS Excellence in Oncology Nursing Health Policy and Advocacy Award

Legislative Updates; 05/20/2011

ONS Health Policy Director Alec Stone congratulates ONS member and 2011 Advocacy Award winner Laurie J. Dohnalek, RN, MBA, NE-BC after receiving her plaque for outstanding contributions in oncology nursing health policy advocacy.

ONS Signs on to Prevent Healthcare-Associated Infections

Legislative Updates; 05/19/2011

The Oncology Nursing Society (ONS) joined the U.S. Department of Health and Human Services along with hospitals, healthcare providers, and other organizations in the Partnership for Patients to make hospital care safer, more reliable, and less costly.

Sebelius Recognizes Nurses for Their Commitment, Leadership, and Vision

Legislative Updates; 05/12/2011

Kathleen Sebelius, secretary of the U.S. Department of Health and Human Services, recognized the contributions of nurses and thanked them for their critical work in an official statement released in honor of National Nurses Week.

FDA Approves Everolimus

FDA Updates; 05/05/2011

The U.S. Food and Drug Administration approved everolimus (Afinitor® Tablets, Novartis Pharmaceuticals Corporation), for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease.

ONS Signs on Support to Maintain Prevention and Public Health Fund

Legislative Updates; 05/04/2011

With the concern about the future implementation of the Patient Protection and Affordable Care Act (PPACA) and the current economic environment, ONS has joined a number of other cancer organizations in raising Congress's awareness of the importance of a key prevention and detection fund included in the original legislation.

ONS Announces 2011-2012 Board of Directors

ONS News; 04/30/2011

The Oncology Nursing Society (ONS) announced its 2011–2012 Board of Directors at its 36th Annual Congress in Boston, MA.

ONS Joins Journey Forward Collaborative to Benefit Cancer Survivors

ONS News; 04/28/2011

The Oncology Nursing Society (ONS) has joined the Journey Forward collaborative to promote cancer survivorship through the use of Survivorship Care Plans.

Judith Johnson, PhD, RN, FAAN, Receives ONS Lifetime Achievement Award

Awards Granted; 04/25/2011

Judith Johnson, PhD, RN, FAAN, is the recipient of the 2011 Oncology Nursing Society (ONS) Lifetime Achievement Award. The award recognizes her outstanding contributions as an oncology nurse researcher, mentor, and educator as well as her service to ONS and the community at large.

Martha Langhorne, MSN, RN, FNP, AOCN®, Receives Pearl Moore Making A Difference Award

Awards Granted; 04/25/2011

Martha Langhorne, MSN, RN, FNP, AOCN®, is the 2011 recipient of the Oncology Nursing Society (ONS) Pearl Moore Making a Difference Award. The award recognizes her significant contributions to the oncology nursing profession at the local and regional levels

ONS Hires Executive Director of Professional Practice and Programs

ONS News; 04/19/2011

The Oncology Nursing Society (ONS) has hired Elizabeth Wertz Evans, RN, BSN, MPM, FACMPE, CPHQ, CPHIMS, to serve as executive director of professional practice and programs. She will lead ONS’s division that oversees education, publishing, research, library/archives, and international initiatives.

ONS Member Patrick Coyne, MSN, APN, FAAN Testifies Before Congressional Committee on Need for Continued Access to Pain Medication for Patients With Cancer

Legislative Updates; 04/14/2011

ONS member Patrick Coyne, MSN, APN, FAAN, was a witness and testified on behalf of the broad patient and provider communities regarding pain relief at a hearing "Warning: The Growing Danger of Prescription Drug Diversion."

FDA Approves Vandetanib Tablets

FDA Updates; 04/12/2011

The U. S. Food and Drug Administration approved vandetanib tablets (Vandetanib Tablets, AstraZeneca Pharmaceuticals LP), a kinase inhibitor, for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable, locally advanced, or metastatic disease. The use of vandetanib in patients with indolent, asymptomatic or slowly progressing disease should be carefully considered because of the treatment-related risks of vandetanib.

ONS Board Makes Changes to National Conference Offerings for 2012

ONS News; 04/11/2011

The ONS Board of Directors approved some exciting new changes to ONS’s national conference offerings at its March 2011 meeting. These changes are in direct response to customer feedback and the changing landscape of healthcare meetings and education.

ONS PEP Resources Now Included in National Guidelines

ONS News; 04/04/2011

ONS’s Putting Evidence Into Practice (PEP®) guidelines are now included in the National Guideline Clearinghouse (NGC), an initiative of the U.S. Department of Health and Human Services’ Agency for Healthcare Research and Quality (AHRQ).

FDA Approves Peginterferon Alfa-2B

FDA Updates; 03/29/2011

The U.S. Food and Drug Administration approved peginterferon alfa-2b (Sylatron™, Schering Corporation, Kenilworth, NJ 07033), for the treatment of patients with melanoma with microscopic or gross nodal involvement within 84 days of definitive surgical resection including complete lymphadenectomy.

FDA Approves Ipilimumab Injection

FDA Updates; 03/25/2011

The U. S. Food and Drug Administration approved ipilimumab injection (YERVOY ®, Bristol-Myers Squibb Company) for the treatment of unresectable or metastatic melanoma.

David Makumi-Kinyanjui, RN, MPC(c), Receives ONS International Award

Awards Granted; 03/24/2011

David Makumi-Kinyanjui, RN, MPC(c), is the 2011 recipient of the Oncology Nursing Society (ONS) International Award for Contributions to Cancer Care. The award recognizes his contribution in drawing the attention of the country to the cancer crisis and his leadership in empowering nurses and ordinary Kenyans with knowledge and skills to respond to the growing cancer problem.

Donna L. Berry, PhD, RN, AOCN®, FAAN, Receives 2011 Oncology Nursing Society Distinguished Researcher Award

Awards Granted; 03/17/2011

Donna L. Berry, PhD, RN, AOCN®, FAAN, has been named the Oncology Nursing Society’s (ONS) 2011 Distinguished Researcher.

Update on the Institute of Medicine Report on the Future of Nursing

ONS News; 03/08/2011

The Oncology Nursing Society (ONS) has developed a number of tactics that address the key messages identified in the Institute of Medicine (IOM) Report on the Future of Nursing, which was published in October 2010.

Bakitas Receives ONS 2011 New Investigator Award

Awards Granted; 02/12/2011

Marie Anne Bakitas, DNSc, APRN, NP-C, AOCN®, ACHPN, FAAN, was presented the Oncology Nursing Society (ONS) 2011 Victoria Mock New Investigator Award today at the ONS 11th National Conference on Cancer Nursing Research in Los Angeles, CA.

Donald Bailey, Jr., PhD, RN, Presents 2011 Oncology Nursing Society State-of-the-Science Lecture

Awards Granted; 02/11/2011

Donald Bailey, Jr., PhD, RN, presented the 2011 Oncology Nursing Society (ONS) State-of-the-Science Lecture, “Illness Uncertainty in Adult Cancer Patients,” today during the ONS 11th National Conference on Cancer Nursing Research in Los Angeles.

Just Being at High Risk for Breast Cancer Is a Life-Changing Experience

Press Releases; 02/11/2011

Young African American women at high risk for breast cancer described the risk itself as a life-changing experience, according to a study released today at the Oncology Nursing Society (ONS) 11th National Conference on Cancer Nursing Research.

Study Supports Forgoing Axillary Dissection in Some Patients With Breast Cancer

ONS News; 02/11/2011

A study published Wednesday in JAMA found that, among a small subset of patients with breast cancer, axillary dissection in patients with sentinel node metastases does not significantly affect survival rates. The study was covered by the mainstream media with a New York Times’ reporter describing it as turning “standard medical practice on its head.” Although the findings are exciting for breast cancer patients, nurses play a key role in helping patients understand the limitations of the findings.

Whether They Smoke or Not, Patients Say Lung Cancer Diagnosis Carries a Social Stigma

Press Releases; 02/11/2011

Patients with lung cancer, whether they smoke or not, feel stigmatized because their disease is strongly associated with smoking, according to a study released today at the Oncology Nursing Society (ONS) 11th National Conference on Cancer Nursing Research.

Study Finds More Survivorship Programs Needed; Time and Funding Present the Greatest Barriers

ONS News; 02/08/2011

An estimated 12 million people are cancer survivors, yet only 27% of nurses working in oncology report that their practice has a formal survivorship program.

FDA Approves Rituximab

FDA Updates; 01/28/2011

the U.S. Food and Drug Administration approved rituximab (Rituxan®, Genentech, Inc) for maintenance therapy for patients with previously untreated follicular, CD-20 positive, B-cell non-Hodgkin lymphoma who achieve a response to rituximab in combination with chemotherapy.

ONS Partners With Advocacy Groups for Ice Skating Spectacular

ONS News; 12/17/2010

The Oncology Nursing Society (ONS) has joined leading cancer advocacy groups and professional associations to support an education and awareness platform around cancer survivorship through a holiday television special called Kaleidoscope on Ice.

LDI on Hold for 2011

ONS News; 12/08/2010

For many years, the ONS Leadership Development Institute (LDI) has brought together hundreds of participants from a variety of backgrounds for a three-day leadership conference followed by a year of mentorship and goal accomplishment. Due to changing needs, the decision has been made to take a step back from our current LDI program in 2011 and allow for a period of assessment and reflection. Therefore, ONS will not offer LDI in 2011. We look forward to a continued tradition of excellence in leadership programming that will address the needs of nurses in the future.

One Nurse is Special to Many

ONS News; 12/08/2010

Of all the nominations received for Honor Someone Special, no one has been named more than Mary Diffendall, RN, OCN®. Mary, an oncology nurse at Connecticut Oncology Group in Middletown, has been nominated for Honor Someone Special 26 times, often by her patients. Here is what is being said about Mary.

FDA Approves Denosumab

FDA Updates; 11/18/2010

The U.S. Food and Drug Administration granted approval for denosumab (Xgeva™, Amgen Inc.) for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors. Denosumab is not indicated for the prevention of SREs in patients with multiple myeloma.

FDA Grants Approval for Eribulin Mesylate

FDA Updates; 11/15/2010

The US Food and Drug Administration granted approval for eribulin mesylate (Halaven™ Injection, Eisai Inc.) for the treatment of patients with metastatic breast cancer who have previously received an anthracycline and a taxane in either the adjuvant or metastatic setting, and at least two chemotherapeutic regimens for the treatment of metastatic disease.

Labeling Changes Regarding Safety Information for Trastuzumab

FDA Updates; 11/02/2010

This notice is to inform you of important new safety information regarding the already labeled adverse reaction of oligohydramnios (decreased amniotic fluid).

FDA Grants Accelerated Approval to Everolimus

FDA Updates; 10/29/2010

the U.S. Food and Drug Administration granted accelerated approval to everolimus (Afinitor®, Novartis), an mTOR inhibitor, for patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS) who require therapy but are not candidates for surgical resection.

ONS Secures New Tenant

ONS News; 10/29/2010

Industrial Scientific Corporation has signed a lease with the Oncology Nursing Society (ONS) in RIDC Park West. The 35,000-square foot Findlay Township location will serve as their primary development and commercial facility. The company’s corporate headquarters is located in Oakdale.

FDA Grants Accelerated Approval to Dasatinib

FDA Updates; 10/28/2010

The U.S. Food and Drug Administration granted accelerated approval to dasatinib [Sprycel®, Bristol-Myers Squibb], an orally administered kinase inhibitor, for the treatment of newly diagnosed adult patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase (CP-CML).

FDA Grants Approval for Trastuzumab in Combination With Other Drugs

FDA Updates; 10/20/2010

The US Food and Drug Administration granted approval for trastuzumab (Herceptin®), Genentech, Inc.), in combination with cisplatin and a fluoropyrimidine (capecitabine or 5-fluorouracil), for the treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal (GE) junction adenocarcinoma, who have not received prior treatment for metastatic disease.

White House Goes Pink to Raise Awareness for Breast Cancer

Legislative Updates; 10/14/2010

At 6:30 pm October 14, the White House was bathed in a soft pink light to make a public statement about breast cancer awareness month.

Changes in Measurement of Serum Creatinine May Impact Carboplatin Dosing

FDA Updates; 10/08/2010

Recent changes in the measurement of serum creatinine may have an impact on carboplatin dosing.

Call for NIWI Applicants

Legislative Updates; 10/07/2010

The Nurse in Washington Internship (NIWI) Program is an annual event sponsored by the Nursing Organizations Alliance (The Alliance). With over 60 member organizations, ONS among them, The Alliance represents approximately 500,000 nurses. The Alliance sponsors the internship to promote the interests of its member groups through education, research, and health-policy activities. Over the years, more than one thousand nurses have attended NIWI, many of whom have become influential participants in the political process at state and federal levels.

ONS Applauds IOM Report on the Future of Nursing

Legislative Updates; 10/07/2010

The Institute of Medicine’s latest consensus report on the “The Future of Nursing: Leading Change, Advancing Health” provides support for the crucial role of nursing in addressing the increased demand for services expected from healthcare reform legislation.

Cindy Tofthagen, PhD, ARNP, AOCNP, Receives ONS Foundation Research Fellowship

Awards Granted; 09/30/2010

ONS Receives Website Honors

Press Releases; 09/30/2010

The Oncology Nursing Society (ONS) was honored by the Web Marketing Association with awards for their website excellence.

Three ONS Members Named Among Top 10 Influential Nursing Professors

Press Releases; 09/24/2010

PITTSBURGH, PA – September 24, 2010 – Three ONS members have been named to the list of the top 10 most influential nursing professors by the Mister Medicine blog.

HRSA Study Finds Nursing Workforce is Growing

Legislative Updates; 09/22/2010

The Health Resources and Services Administration (HRSA) recently presented a report showing that the nursing workforce increased by more than 5% between 2004 and 2008.

Johanns' Amendment Rejected by US Senate

Legislative Updates; 09/13/2010

The United States Senate rejected Senator Mike Johanns’ (R-NE) amendment to the Small Business Jobs and Credit Act.

ONS Prepares for Fall Conferences

ONS News; 08/12/2010

ONS prepares for the 11th Annual Institutes of Learning and ONS Advanced Practice Nursing Conferences in Orlando.

Oncology Nursing Society Sponsors the Institute of Medicine’s National Cancer Policy Forum

Press Releases; 07/30/2010

PITTSBURGH, PA – July 30, 2010 – The Oncology Nursing Society (ONS) is pleased to announce its sponsorship of the Institute of Medicine’s (IOM) National Cancer Policy Forum. The Forum explores emerging policy issues in the nation’s effort to combat cancer and enables all members to be full participants in identifying and debating critical issues and examining potential actions.

ONS President Addresses FDA

Legislative Updates; 07/26/2010

PITTSBURGH, PA – July 26, 2010 – Oncology Nursing Society (ONS) President Carlton Brown, RN, PhD, AOCN®, testified before a U.S. Food and Drug Administration (FDA) committee in Washington, DC, regarding the proposed Risk Evaluation and Mitigation Strategies (REMS) for Extended-Release and Long-Acting Opioid Analgesics, which seeks to address the issue of opioid misuse and abuse. The CoC has replied to the letter, indicating that it intends to take some of ONS’s suggestions.

Healthcare Reform: What Does it Mean to You and Your Patients?

Legislative Updates; 07/17/2010

View slide presentation from the 2010 ONS Mentorship session.

ONS Celebrates Milestone

Press Releases; 07/02/2010

PITTSBURGH, PA – July 2, 2010 – The Oncology Nursing Society (ONS) is celebrating its 35th anniversary as a professional association providing membership benefits to more than 36,000 registered nurses who specialize in caring for patients with cancer.

Pfizer Inc. Announces that Commercial Marketing of Mylotarg (gemtuzumab ozogamicin) Will be Voluntarily Discontinued and the New Drug Application for Mylotarg Will be Withdrawn as of October 15, 2010.

FDA Updates; 06/21/2010

On June 21, 2010, Pfizer Inc., in agreement with the FDA, announced that the commercial marketing of Mylotarg (gemtuzumab ozogamicin) will be voluntarily discontinued, and the new drug application (NDA) for Mylotarg will be withdrawn as of October 15, 2010.

FDA Approves Cabazitaxel

FDA Updates; 06/17/2010

On June 17, 2010, the U.S. Food and Drug Administration (FDA) approved cabazitaxel (Jevtana® Injection, sanofi-aventis) for use in combination with prednisone for treatment of patients with metastatic hormone-refractory prostate cancer (mHRPC) previously treated with a docetaxel-containing regimen.

FDA Grants Accelerated Approval to Nilotinib

FDA Updates; 06/17/2010

On June 17, 2010, the U. S. Food and Drug Administration granted accelerated approval to nilotinib (Tasigna® Capsules, Novartis Pharmaceuticals Corporation), an orally administered kinase inhibitor, for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP-CML).

ONS Awarded for Publishing Excellence

Press Releases; 06/15/2010

PITTSBURGH, PA – June 15, 2010 – The Oncology Nursing Society (ONS) was honored by the Association Media and Publishing as a winner of the esteemed EXCEL Award in two categories at its recent 30th Annual EXCEL Awards Gala in Washington, DC.

ONS Provides Key Nursing Resources to Support Cancer Clinical Trials Recommendations

ONS News; 05/28/2010

The Oncology Nursing Society’s (ONS’s) long-standing efforts to support clinical trials funding and access to participation are in line with recommendations offered in the Institute of Medicine’s (IOM’s) recent report on the Cooperative Group Program and the American Society of Clinical Oncology’s (ASCO’s) response to the report.

New bill delays medicare pay cut until 2014, provides raises in interim.

Legislative Updates; 05/20/2010

Congressional Democrats today unveiled the outline of a bill that would delay a 21% cut in Medicare reimbursement to physicians until 2014 and increase rates for the rest of 2010 as well as 2011.

ONS Announces 2010–2011 Board of Directors

Press Releases; 05/15/2010

SAN DIEGO, CA – May 15, 2010 – The Oncology Nursing Society (ONS) announced its 2010–2011 Board of Directors at its 35th Annual Congress in San Diego, CA.

Connie Henke Yarbro, MS, RN, FAAN, Receives 2010 Oncology Nursing Society Lifetime Achievement Award

Awards Granted; 05/13/2010

SAN DIEGO, CA – May 13, 2010 – Connie Henke Yarbro, MS, RN, FAAN, of Destin, FL, is the recipient of the 2010 Oncology Nursing Society (ONS) Lifetime Achievement Award. Yarbro is the editor of Seminars in Oncology Nursing and an adjunct clinical associate professor at the University of Missouri-Columbia Sinclair School of Nursing. The award, presented today at the ONS 35th Annual Congress held in San Diego, CA, recognizes her outstanding contributions as an oncology nurse researcher, mentor, and educator as well as her service to ONS and the community at large.

Oncology Nursing and Social Work Professional Associations

Press Releases; 04/13/2010

PITTSBURGH, PA – April 13, 2010 – The Oncology Nursing Society (ONS), the Association of Oncology Social Work (AOSW), and the National Association of Social Workers (NASW) worked together to develop a joint position statement on the role of oncology nursing and oncology social work in patient navigation.

New ESA Risk Management System

Legislative Updates; 02/16/2010

ONS Joins the Nursing Community to Advocate for Nursing Provisions

Legislative Updates; 01/06/2010

ONS joined with others in the nursing community to advocate for nursing provisions.

ONS Members Attend White House Briefing

Legislative Updates; 09/10/2009

ONS Written Comments to the FDA

Legislative Updates; 06/26/2009

ONS submitted written comments to the Food and Drug Administration (FDA) related to the possibility that the FDA will create a Risk Evaluation and Mitigation Strategies (REMS) for certain opioid drugs.

ONS Testimony for FDA Public Opioid REMS Meeting

Legislative Updates; 05/27/2009

This is a synopsis of the testimony ONS delivered to the FDA on May 27th, 2009.

Commitment to Quality Health Reform

Legislative Updates; 05/01/2009

Commitment to Quality Health Reform: A Consensus Statement from the Nursing Community

Health Policy Update April 2009

Legislative Updates; 04/01/2009

Health Policy Update April 2009

Cancer and Nursing in the Stimulus Package

Legislative Updates; 02/17/2009

President Obama signed the economic stimulus bill (H.R. 1) into law.